Effect of nicardipine on rest and exercise hemodynamics in chronic congestive heart failure

The American Journal of Cardiology
K S RymanR J Cody

Abstract

The hemodynamic response to vasodilation induced by the new calcium channel antagonist nicardipine was studied in 10 patients with severe, chronic congestive heart failure. Rest and exercise hemodynamics were evaluated in the baseline state and after 1 week of oral nicardipine therapy (30 mg 3 times daily). In addition, respiratory gas exchange and arteriovenous oxygen difference were measured to assess changes in oxygen utilization. The responses of the sympathetic nervous system were evaluated by measuring plasma norepinephrine concentrations at rest and during maximal exercise. At rest, nicardipine administration was associated with significant reductions in mean systemic arterial pressure, systemic vascular resistance, pulmonary artery wedge pressure and pulmonary arterial pressure, and significant increases in cardiac index and stroke volume index. These effects were maintained during exercise. In contrast to findings with other calcium channel antagonists, no negative inotropic effect of nicardipine was identified. Nicardipine administration was associated with reduction of arteriovenous oxygen difference. Nicardipine had no effect on plasma norepinephrine concentrations, suggesting absence of reflex sympathetic nervous a...Continue Reading

References

May 1, 1977·Progress in Cardiovascular Diseases·D T MasonG Lee
Mar 1, 1985·Journal of the American College of Cardiology·M A FiferW H Barry
Apr 1, 1985·Journal of the American College of Cardiology·G S FrancisJ N Cohn
Sep 15, 1985·The American Journal of Cardiology·U ElkayamS Rahimtoola
Sep 1, 1982·Journal of Cardiovascular Pharmacology·F BellocciU Manzoli
Dec 1, 1980·The American Journal of Cardiology·P D Henry
Nov 1, 1983·The American Journal of Medicine·X E PridaR J Cody
Apr 1, 1980·British Heart Journal·S KlugmannF Camerini

❮ Previous
Next ❯

Citations

Jul 1, 1988·Cardiovascular Drugs and Therapy·L H Opie
Jan 1, 1999·Progress in Cardiovascular Diseases·N Mahon, W J McKenna
Jan 1, 1997·Clinical Therapeutics·P E Pool
Jul 23, 1998·Clinical and Experimental Pharmacology & Physiology·K NoguchiM Sakanashi
Jan 20, 2004·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Isabelle MahéJean-François Bergmann
Oct 4, 2007·Journal of the American Geriatrics Society·Paul A Heidenreich, Gregg C Fonarow
Dec 1, 1996·Journal of Cardiac Failure·M A KonstamJ E Udelson
Jan 1, 1988·Annals of the New York Academy of Sciences·S H KuboJ N Cohn
Feb 3, 2016·Clinical Medicine : Journal of the Royal College of Physicians of London·Eleanor C Wicks, Lewis C Davies
Mar 1, 1994·Journal of Anesthesia·Satoshi KashimotoTeruo Kumazawa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.